Ta'lim innovatsiyasi va integratsiyasi
https://scientific-jl.com
45-son_4-to’plam_May -2025
200
ISSN:3030-3621
KIDNEY DISEASES AND THEIR PATHOGENESIS: A SCIENTIFIC
OVERVIEW
Yusupova Maftuna Azamatovna
Bukhara State Medical Institute
named after Abu Ali ibn Sina, Bukhara,
Uzbekistan maftuna.yusupova@ bsmi.uz
Abstract:
Kidney diseases encompass a broad spectrum of disorders affecting
the structure and function of the kidneys. Understanding the pathogenesis of these
diseases is essential for effective diagnosis, treatment, and prevention. This article
reviews common kidney diseases, including glomerulonephritis, diabetic nephropathy,
and chronic kidney disease (CKD), and discusses the molecular and cellular
mechanisms underlying their development and progression.
Keywords:
Kidney diseases, pathogenesis, glomerulonephritis, chronic kidney
disease, nephropathy, renal failure, inflammation, fibrosis
1. Introduction
Kidneys play a vital role in maintaining homeostasis by filtering blood,
regulating electrolytes, and eliminating waste. Pathological changes in the kidneys can
lead to impaired function, ultimately resulting in renal failure. Kidney diseases may be
acute or chronic, with diverse etiologies and pathophysiological mechanisms.
2. Classification of Kidney Diseases
Kidney diseases are commonly classified into:
Glomerular diseases:
Affect the glomeruli, such as glomerulonephritis.
Tubulointerstitial diseases:
Affect tubules and interstitium, including
interstitial nephritis.
Vascular diseases:
Affect renal blood vessels, e.g., hypertensive
nephrosclerosis.
Cystic kidney diseases:
Genetic disorders like polycystic kidney disease.
3. Pathogenesis of Kidney Diseases
3.1 Immune-Mediated Injury
Glomerulonephritis involves immune complex deposition in glomeruli,
activating complement pathways and inflammatory cells that damage the filtration
barrier.
3.2 Metabolic Factors
Diabetic nephropathy arises due to chronic hyperglycemia causing advanced
glycation end-products (AGEs) accumulation, oxidative stress, and activation of pro-
fibrotic pathways, leading to glomerulosclerosis and tubulointerstitial fibrosis.
Ta'lim innovatsiyasi va integratsiyasi
https://scientific-jl.com
45-son_4-to’plam_May -2025
201
ISSN:3030-3621
3.3 Hemodynamic Changes
Hypertension and hyperfiltration damage glomerular capillaries, increasing
permeability and proteinuria, which further promote inflammation and fibrosis.
3.4 Cellular and Molecular Mechanisms
Persistent injury stimulates mesangial cell proliferation, extracellular matrix
deposition, and cytokine release (e.g., TGF-β, TNF-α), driving fibrosis and scarring.
4. Clinical Implications
Understanding pathogenesis informs therapeutic strategies such as
immunosuppressive treatment for immune-mediated diseases and tight glycemic and
blood pressure control in diabetic nephropathy and hypertensive nephrosclerosis,
respectively.
5. Conclusion
Kidney diseases result from complex interactions of immune, metabolic, and
hemodynamic factors that disrupt normal renal architecture and function. Advances in
understanding their pathogenesis provide opportunities for improved management and
outcomes.
References
1.
Nangaku, M.
(2006). Pathogenesis of chronic kidney disease.
Clin Exp Nephrol
,
10(4), 257–265.
https://doi.org/10.1007/s10157-006-0450-7
2.
Pichler, R., Afkarian, M., Dieter, B. P., & Tuttle, K. R.
(2017). Immunity and
inflammation in diabetic kidney disease: Translating mechanisms to biomarkers
and treatment targets.
American Journal of Physiology-Renal Physiology
, 312(5),
F716–F731.
https://doi.org/10.1152/ajprenal.00342.2016
3.
Liu, Y.
(2011). Cellular and molecular mechanisms of renal fibrosis.
Nature
Reviews Nephrology
, 7(12), 684–696.
https://doi.org/10.1038/nrneph.2011.149
4.
Levey, A. S., Coresh, J.
(2012). Chronic kidney disease.
The Lancet
, 379(9811),
165–180.
https://doi.org/10.1016/S0140-6736(11)60178-5
5.
Kang, H. M., Ahn, S. H., Choi, P., Ko, Y. A., Han, S., Chinga, F., ... &
Humphreys, B. D.
(2015). Defective fatty acid oxidation in renal tubular epithelial
cells has a key role in kidney fibrosis development.
Nature Medicine
, 21(1), 37–46.
https://doi.org/10.1038/nm.3757